Discipline: A - Track: Five

学科：A - 赛道：五

• 批准号: 10175974
• 负责人: Gil Kelley
• 金额: $ 7.5万
• 依托单位: WISCONSIN DEPT/AGRI/TRADE/CONSUM/ PROT
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-01 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10175974
• 关键词: Discipline; Track; Five

Project Summary DA/T5 Microbiology Capability/Capacity Development - Cyclospora The purpose of this analytical track is to build additional capability and expand the national capacity in microbiological areas of emerging technology and/or where FDA has identified a specific need. Goal: Develop the capability to test for Cyclospora in human food product and environmental samples. Cyclospora is an emerging pathogen of interest in Wisconsin and throughout the US. A dependable method for recovering the organism in food and water samples does/did not exist until recently, making the identification of outbreaks related to this organism difficult to assess. FDA has recently come out with a more dependable method of testing for this organism. Wisconsin has been involved in two suspected outbreaks of Cyclospora in the past two year, but WI BLS was unable to do the testing the Division of Food and Recreation safety (DFRS) requested. WI BLS has already sent one of its staff members, Jay Lee, FERN training on Cyclospora (LB 302). In addition, he has attended multiple webinar updates on the method. Cyclospora is a method WI would like to add to its scope. Granting WI BLS this track enhances our ability to meet DFRS needs, and meets the goal of improved capacity and capabilities as out lined in the grant.

项目摘要 DA/T5 微生物学能力/能力开发-环孢菌 这一分析轨道的目的是建立更多的能力，并扩大国家在以下方面的能力： 新兴技术和/或FDA已确定特定需求的微生物领域。 目标：发展检测人类食品和环境样品中环孢子虫的能力。 环孢菌是威斯康星州和整个美国感兴趣的新兴病原体。一个可靠 回收食物和水样本中有机体的方法直到最近才存在， 与该生物体有关的暴发的确定难以评估。FDA最近发布了 一种更可靠的检测方法 威斯康星州在过去的两年里已经卷入了两次疑似环孢子虫疫情，但威斯康星州的BLS 无法进行食品和娱乐安全部门（DFRS）要求的测试。 WI BLS已经派出了一名工作人员，杰伊李，对环孢菌（LB 302）进行FERN培训。在 此外，他还多次参加关于该方法的网络研讨会。 环孢子虫是一种方法，我想添加到其范围。授予WI BLS这条赛道增强了我们的能力 以满足DFRS的需求，并满足赠款中列出的提高能力和能力的目标。